In 2012, Abbott Labs is planning to split into two separate companies with completely different objectives, according to an announcement issued by the company.  Increasing shareholder value was cited in making the announcement and the decision is expected to appeal to investors who want differing levels of risks and rewards. One of the new companies will focus on diagnostics and medical devices, such...